Home Cart 0 Sign in  

[ CAS No. 40216-83-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 40216-83-9
Chemical Structure| 40216-83-9
Structure of 40216-83-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 40216-83-9 ]

Related Doc. of [ 40216-83-9 ]

Alternatived Products of [ 40216-83-9 ]

Product Details of [ 40216-83-9 ]

CAS No. :40216-83-9 MDL No. :MFCD00080855
Formula : C6H12ClNO3 Boiling Point : -
Linear Structure Formula :- InChI Key :-
M.W : 181.62 Pubchem ID :-
Synonyms :
H-Hyp-OMe hydrochloride

Calculated chemistry of [ 40216-83-9 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.83
Num. rotatable bonds : 2
Num. H-bond acceptors : 4.0
Num. H-bond donors : 2.0
Molar Refractivity : 44.97
TPSA : 58.56 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.24 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.0
Log Po/w (XLOGP3) : 0.24
Log Po/w (WLOGP) : -0.7
Log Po/w (MLOGP) : -0.5
Log Po/w (SILICOS-IT) : -0.25
Consensus Log Po/w : -0.24

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.99
Solubility : 18.8 mg/ml ; 0.103 mol/l
Class : Very soluble
Log S (Ali) : -1.03
Solubility : 16.9 mg/ml ; 0.0933 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -0.06
Solubility : 159.0 mg/ml ; 0.873 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.51

Safety of [ 40216-83-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 40216-83-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 40216-83-9 ]
  • Downstream synthetic route of [ 40216-83-9 ]

[ 40216-83-9 ] Synthesis Path-Upstream   1~30

  • 1
  • [ 40216-83-9 ]
  • [ 2438-57-5 ]
Reference: [1] Tetrahedron Letters, 1998, vol. 39, # 10, p. 1169 - 1172
  • 2
  • [ 40216-83-9 ]
  • [ 52683-81-5 ]
Reference: [1] Tetrahedron Letters, 1998, vol. 39, # 10, p. 1169 - 1172
  • 3
  • [ 67-56-1 ]
  • [ 32968-78-8 ]
  • [ 40216-83-9 ]
YieldReaction ConditionsOperation in experiment
92% at 0 - 20℃; Reflux Example 1 : methyl ("2S,4R)-4-hvdroxy-2-pyrrolidinecarboxylate hydrochloride To a solution of (2S,4R)- 4-hydroxy-2-pyrrolidinecarboxylic acid hydrochloride (1.0 g, 7.6 mmol) in methanol (25 mL) at 0 °C was added thionyl chloride (0.83 mL, 1 1.4 mmol). The reaction was warmed to room temperature and heated at reflux overnight. After cooling to room temperature, the reaction mixture was concentrated to dryness to give the title compound (1.2 g, 92percent) as a white solid. lH NMR (300 MHz, DMSO-<) δ 9.99 (br. s, 2H), 5.58 (br. s, 1H), 4.49-4.41 (m, 2H), 3.75 (s, 3H), 3.38 (dd, 1H), 3.07 (d, 1H), 2.23-2.04 (m, 2H)
92% at 0℃; Reflux To a solution of (2S,4R)-4-hydroxy-2-pyrrolidinecarboxylic acid hydrochloride (1.0 g, 7.6 mmol) in methanol (25 mL) at 0° C. was added thionyl chloride (0.83 mL, 11.4 mmol).
The reaction was warmed to room temperature and heated at reflux overnight.
After cooling to room temperature, the reaction mixture was concentrated to dryness to give the title compound (1.2 g, 92percent) as a white solid.
1H NMR (300 MHz, DMSO-d6) δ 9.99 (br. s, 2H), 5.58 (br. s, 1H), 4.49-4.41 (m, 2H), 3.75 (s, 3H), 3.38 (dd, 1H), 3.07 (d, 1H), 2.23-2.04 (m, 2H).
Reference: [1] Organic Letters, 2018, vol. 20, # 1, p. 162 - 165
[2] Patent: WO2013/174937, 2013, A1, . Location in patent: Page/Page column 74
[3] Patent: US2015/152048, 2015, A1, . Location in patent: Paragraph 0447-0448
  • 4
  • [ 67-56-1 ]
  • [ 51-35-4 ]
  • [ 40216-83-9 ]
YieldReaction ConditionsOperation in experiment
100% at 0 - 20℃; for 2.5 h; To a stirred solution of (2S, 4i?)-4-hydroxypyrrolidine-2-carboxylic acid (13.1 g, 0.1 mol) in methanol (400 mL) cooled to 0°C was added acetyl chloride (14.3 mL, 0.2 mol) over a period of 30 min. The reaction mixture was warmed to room temperature and stirred for 2 h. The volatiles were removed under reduced pressure and the residue was triturated with ether several times to get methyl (25',4/?)-4-hydroxypyrrolidine-2- carboxylate hydrochloride salt as a white powder (14.5 g) in 100percent yield, m/z (M+l) 145; 1H NMR (DMSOd6) 300 MHz δ 5.7-5.5 (s (br), IH), 4.55-4.35 (m, 2H), 3.76 (s, 3H), 3.35 (d, J= 12 Hz IH), 3.10 (d, J= 12 Hz IH), 2.25-2.0 (m, 2H).
100% With hydrogenchloride; thionyl chloride In water at 20℃; for 18 h; Reflux A solution of trans-4-hydroxy-ι-proline (10.0 g, 76.3 mmol) in MeOH (80 mL) was cooled to 0 °C andthionyl chloride (11.1 mL, 152 mmol) was added dropwise. The mixture was allowed to stir at roomtemperature for 1 h before being heated under reflux for a further 17 h. The resulting solution wasconcentrated and the residue azeotroped with MeOH (3 × 200 mL) to give the desired compound14·HCl (13.6 g, 100percent) as a colourless solid; mp 169–171 °C;−21.6 (c 1.0, EtOH); νmax/cm-1 3317,2952, 2707, 1740, 1439, 1240, 1074, 1025, 956, 901, 625; δH (500 MHz; MeOD) 4.63–4.59 (2 H, m),3.86 (3 H, s), 3.46 (1 H, dd, J 3.2, 10.0 Hz), 3.34–3.30 (1 H, m), 2.45–2.41 (1 H, m), 2.21 (1 H, ddd, J2.4, 8.0, 11.2 Hz); δC (125 MHz; CDCl3) 170.6, 70.6, 59.4, 55.0, 54.0, 38.6; m/z (+ESI) 146 ([M - Cl],100).
100% at 0 - 64℃; for 8 h; At room temperature,Trans-4-hydroxy-L-proline 2A (20.0 g, 152.6 mmol) was dissolved in anhydrous methanol (200 mL)Cooling to 0 ,Dichloro sulfoxide (20.6g, 172.4mmol),The temperature was raised to 64 ° C and the reaction was refluxed for 8 hours.The reaction solution was lowered to -20 ° C, and a white solid was precipitated. Methyl tertiary butyl ether (50 mL) was added and the reaction was continued for 30 minutes.The filter cake was washed with methyl tertiary butyl ether (50 mL x 2) and dried to give white solid 4A (28 g, yield 100percent).
99% at 0℃; for 8 h; Heating / reflux Acetyl chloride (4.14 g, 52.8 mmol) is dropped into a three neck round bottom flask containing anhydrous methanol (33 ml) in ice bath and under N2 flux. [(2S,4R)-(-)-4-Hydroxypyrrolidine-2-carboxylic acid (1) (5.0 g, 37.7 mmol) is added and the so obtained reaction mixture is firstly brought to room temperature (r.t.) then refluxed for 8 hours. Afterwards, the reaction is brought to room temperature and diethyl ether is added till complete precipitation of the reaction product, which, after Buchner filtration, is (2S,4R)-4-hydroxy-2-(methoxy- carbonyl)pyrrolidine chloride (2). Yield 99percent; white solid m.p. 149-152 0C.1H NMR (DMSO, 500 MHz): δ 2.07 (ddd, IH, J = 4.5, 11.0, 13.0 Hz), 2.18 (m, IH), 3.05 (d, IH, J =12.0 Hz), 3.35 (m, IH), 3.74 (s, 3H, OMe), 4.40 (t, IH, J = 4,5 Hz), 4.44 (dd, IH, J = 6.5, 11.0 Hz), 4.68 (bs, OH), 9.32 (IH, NH), 10.44 (IH, NH).13C NMR (DMSO, 50 MHz): δ 37.0, 53.0, 57.4, 57.8, 68.4, 169.0.Elemental analysis. Calculated for C6Hi2ClNO3: C, 39.68; H, 6.66; Cl, 19.52; N, 7.71. Found: C, 39.66; H, 6.64; Cl, 19.50; N, 7.71. Theoretical mass for C6Hi2ClNO3: 181.05. Found: 181.00.
98%
Stage #1: for 0.166667 h; Inert atmosphere
Stage #2: at 0℃; Inert atmosphere
4-Hydroxy proline (10.0 g, 76.33 m mol)dissolved in dry methanol (150 ml) and stirred for 10 minutes under nitrogen atmosphere.The reaction mixture cooled to 0°C by ice bath and thionyl chloride (152.6 mmol, 11.07 ml)added dropwise under nitrogen atmosphere .The ice bath removed and the reaction mixturerefluxed for six hours. The solvents were removed under reduced pressure to obtain a whitesolid which was dissolved in methanol and again evapourated to dryness to yield 13.54 g ofthe title compound in 98percent yield.
96% With thionyl chloride In neat (no solvent) at 0 - 25℃; for 16 h; To a stirred solution of (25,4R)-4-hydroxypyrrolidine-2-carboxylic acid (75.0 g, 572 mmol) in MeOH (800 mL), SOCI2 (75 mL) was added at 0 °C and the reaction mixture was stirred at room temperature for 16 h. After consumption of the starting material (by TLC), the reaction mixture was concentrated under reduced pressure. The residue was triturated with Et20 (500 mL x 2), filtered, dried to afford compound 1 (100.0 g, 96percent) as a white solid as a HCI salt of compound 1. LCMS (ESI): m/z 146.0 [M++l].
95% at -78℃; for 4.16667 h; Heating / reflux Step 1 : (2S,4R)-methyl 4-hydroxypyrrolidine-2-carboxylate hydrochloride (2). Thionyl chloride (11.6 ml, 160 mmol) was added to a stirred solution of (2S,4R)-4- hydroxypyrrolidine-2-carboxylic acid (10.0 g, 76.26 mmol) (1) in methanol (150 ml) at - 780C for 10 min. The mixture was then stirred in an ice bath for 30 minutes followed by stirring at RT for 30 min. Finally the mixture was refluxed for three hours and concentrated in vacuo to give (2S,4R)-methyl 4-hydroxypyrrolidine-2-carboxylate hydrochloride (2) (17.90 g, 95percent) as a white solid. Used without further purification. MS m/z 146.2 (M+H)+; retention time = 0.19 min, method [I].
94% at 0 - 45℃; for 4 h; SOCl2 (5.2 mL,71.3 mmol) was dissolved in 35.0 mL of anhydrous MeOHat 0 oC.Then trans-4-OH-proline (5.0 g, 38.1 mmol) was added and the reactionmixture was kept refluxing at 45 oC for 4 h, then the solvent was evaporated undervacuum. The residue was dissolved with methanol and recrystallized with diethylether to afford 15 as a white solid (6.5 g, 94percent yield). mp:167.3-167.5 oC; 1H NMR (600 MHz, D2O) δ 4.57–4.65 (m, 2H), 3.76 (s, 3H), 3.44 (dd, J = 12.5, 3.7 Hz, 1H), 3.32 (d, J = 12.6 Hz, 1H), 2.40 (dd, J = 13.5, 7.5 Hz, 1H), 2.21 (ddd, J = 14.3, 10.6, 4.0 Hz, 1H). 13C NMR (150 MHz, D2O) δ 170.24, 69.42, 58.16, 53.84, 53.46,36.68; IR (KBr, cm-1): ν 3328.59, 2960.67, 2869.04, 2705.78, 2602.05, 2421.58,1742.53, 1592.75, 1444.85, 1335.67, 1288.54, 1248.41, 1184.02, 1074.38, 1036.12, 958.20,902.21, 863.95, 710.91, 639.52; HRMS (ESI): m/z calculated forC6H12NO2 (M+H)+: 146.0817, found:146.0813.
92% at 10 - 45℃; for 5 h; Absolute methanol (8.0 equiv) was poured into a four-necked flask equipped with a mechanical stirrer, thermometer, reflux condenser and a drop funnel. L-hydroxyproline (1 equiv) was placed into the flask with stirring. To the suspension obtained was added dropwise at 10-15 0C distilled thionyl chloride (1.1 equiv). Then the mixture was stirred at 45 0C until TLC indicated completion (5 h) of the reaction. The suspension was cooled to 5-10 0C and then filtered and washed with dry diethyl ether. The mother liquor was evaporated in vacuo and the residue was recrystallized from dry methanol to give the title compound in 92-97percent yield.
90% for 2 h; Reflux 26.2 g (200 mmol) trans-4-hydroxy-L-proline (1) in methanol(300 ml) was treated with dry hydrogen chloride until homogeneous.The solution was heated to the reflux temperature for 2 h and concentrated in vacuo. Upon cooling, the product was crystallizedfrom the solvent, collected by filtration, washed with acetoneand ether, and dried to yield trans-4-hydroxy-L-proline methylesterhydrochloride (2) as white crystal (32.7 g, 90percent), mp 159–162 C.
88%
Stage #1: for 0.5 h; Cooling with ice
Stage #2: for 4 h; Reflux
Acetyl chloride (14 mL, 198 mmol) was slowly added into the anhydrous methanol (100 mL) in an ice bath.
After stirred for 30 min, compound 2 (7.87 g, 60.0 mmol) was added to the solution.
Then the reaction was refluxed for 4 h in an oil bath.
After the methanol was removed under reduced pressure, about 10 mL acetone was added into the residue and filtered to give 8.67 g of (2S,4R)-methyl 4-hydroxypyrrolidine-2-carboxylate hydrochloride as a white powder. Yield: 88percent, mp: 160-164 °C. Di-tert-butyl dicarbonate (11.42 g, 52.3 mmol) in 50 mL dichloromethane was slowly added to the solution of (2S,4R)-methyl 4-hydroxypyrrolidine-2-carboxylate hydrochloride (8.64 g, 47.6 mmol), triethylamine (13.5 mL, 96.0 mmol) in 150 mL dichloromethane.
After stirred overnight at room temperature, the reaction mixture was concentrated under reduced pressure and dissolved with EtOAc.
The EtOAc layer was washed two times by 1 M citric acid, saturated sodium bicarbonate and brine, respectively.
Finally, the organic layer was dried over anhydrous MgSO4 and concentrated to obtain compound 3 as a white powder. Yield: 88percent, mp: 93-94 °C. 1H NMR (CDCl3, 300 MHz), δ 1.41 (s, 9H), 2.06-2.09 (m, 1H), 2.27-2.34 (m, 1H), 3.43-3.64 (m, 2H), 3.73 (s, 3H), 4.37-4.48 (m, 2H), ESI-MS m/z: 246.3 (M+H)+.
87% at 0 - 20℃; Trans-4-hydroxy-L-proline (15.0 g, 114.3 mmol) in dry methanol (250 mL) at 0 - 4 °C, was added dropwise thionyl chloride (17 ml .. 231 mmol). The resulting mixture was sl irrcd for at RT overnight, concentrated, crystallized with EtOH/hexane to provide the title compound (18.0 g, 87percent yield), ESI MS m//+ 168.2 (M + Na).
87% at 0 - 20℃; To a solution of trans-4-hydroxy-L-proline (15.0 g, 114.3 mmol) in dry methanol (250 mL) was added thionyl chloride (17 mL, 231 mmol) dropwise at 0 to 4 °C. The resulting mixture was stirred for at r.t. overnight, concentrated, crystallized with EtOH/hexane to provide the title compound (18.0 g, 87percent yield). ESI MS m/z 168.2 ([M+Na]+).
20.5 g at 0 - 20℃; Step-1:
Synthesis of (2S,4R)-methyl 4-hydroxypyrrolidine-2-carboxylate
To a suspension of (2S,4R)-4-hydroxypyrrolidine-2-carboxylic acid (15 g, 114.5 mmol) in MeOH (150 mL) was added SOCl2 (17 mL, 229 mmol) dropwise at 0° C.
The resultant mixture was allowed to stir at RT overnight.
The reaction mixture was concentrated under vacuum, azeotroped with toluene and dried to afford (2S,4R)-methyl 4-hydroxypyrrolidine-2-carboxylate as the HCl salt (20.5 g).

Reference: [1] Tetrahedron, 1995, vol. 51, # 9, p. 2719 - 2728
[2] Journal of Organic Chemistry, 1996, vol. 61, # 14, p. 4748 - 4755
[3] Tetrahedron, 1998, vol. 54, # 44, p. 13391 - 13404
[4] Heterocycles, 2005, vol. 65, # 7, p. 1705 - 1711
[5] Journal of the American Chemical Society, 2001, vol. 123, # 42, p. 10245 - 10254
[6] Organic Letters, 2001, vol. 3, # 8, p. 1241 - 1244
[7] Journal of Organic Chemistry, 2001, vol. 66, # 10, p. 3593 - 3596
[8] Tetrahedron, 2007, vol. 63, # 30, p. 7112 - 7119
[9] Heterocycles, 2003, vol. 60, # 5, p. 1203 - 1209
[10] Journal of the Chinese Chemical Society, 2007, vol. 54, # 3, p. 803 - 806
[11] Patent: WO2007/113634, 2007, A1, . Location in patent: Page/Page column 60
[12] Tetrahedron Asymmetry, 2009, vol. 20, # 12, p. 1433 - 1436
[13] Journal of Organic Chemistry, 2012, vol. 77, # 11, p. 4917 - 4923
[14] Tetrahedron Letters, 2012, vol. 53, # 30, p. 3847 - 3849
[15] Tetrahedron Letters, 2013, vol. 54, # 39, p. 5345 - 5347
[16] Patent: TW2017/8221, 2017, A, . Location in patent: Page/Page column 44
[17] Synlett, 2004, # 6, p. 1003 - 1006
[18] European Journal of Medicinal Chemistry, 2006, vol. 41, # 11, p. 1347 - 1351
[19] Patent: WO2007/65883, 2007, A1, . Location in patent: Page/Page column 6; 13; 29-30
[20] Journal of the Chemical Society - Perkin Transactions 1, 1998, # 22, p. 3777 - 3793
[21] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 18, p. 4016 - 4022
[22] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 24, p. 5424 - 5428
[23] Bioorganic and Medicinal Chemistry Letters, 2000, vol. 10, # 13, p. 1421 - 1425
[24] European Journal of Medicinal Chemistry, 1996, vol. 31, # 9, p. 717 - 723
[25] Heterocycles, 1998, vol. 48, # 11, p. 2365 - 2378
[26] Patent: WO2018/26792, 2018, A1, . Location in patent: Page/Page column 138
[27] Journal of Heterocyclic Chemistry, 1990, vol. 27, # 7, p. 2181 - 2187
[28] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 12, p. 3767 - 3770
[29] Journal of Organic Chemistry, 2018, vol. 83, # 11, p. 6162 - 6170
[30] Patent: WO2008/147800, 2008, A1, . Location in patent: Page/Page column 90
[31] Chemical communications (Cambridge, England), 2003, # 20, p. 2606 - 2607
[32] Tetrahedron Letters, 2015, vol. 56, # 26, p. 4036 - 4038
[33] Journal of Organic Chemistry, 1991, vol. 56, # 23, p. 6672 - 6682
[34] Helvetica Chimica Acta, 1996, vol. 79, # 7, p. 1825 - 1842
[35] Journal of the American Chemical Society, 1998, vol. 120, # 30, p. 7439 - 7449
[36] Patent: WO2006/27694, 2006, A1, . Location in patent: Page/Page column 69
[37] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 11, p. 3055 - 3064
[38] Organic and Biomolecular Chemistry, 2014, vol. 12, # 47, p. 9638 - 9643
[39] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 24, p. 7685 - 7693
[40] Synthesis, 1990, vol. 1, # 10, p. 925 - 930
[41] Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1989, vol. 28, # 1-11, p. 294 - 296
[42] Bioorganic and Medicinal Chemistry, 2008, vol. 16, # 10, p. 5398 - 5404
[43] European Journal of Medicinal Chemistry, 2008, vol. 43, # 10, p. 2130 - 2139
[44] Bioorganic and Medicinal Chemistry, 2008, vol. 16, # 17, p. 7932 - 7938
[45] Patent: WO2015/28850, 2015, A1, . Location in patent: Page/Page column 84; 85
[46] Patent: WO2016/59622, 2016, A2, . Location in patent: Page/Page column 124
[47] Journal of Chemical Research, 2009, # 11, p. 668 - 670
[48] Journal of Organic Chemistry, 1981, vol. 46, # 21, p. 4182 - 4187
[49] Tetrahedron Asymmetry, 1998, vol. 9, # 1, p. 47 - 53
[50] Bioorganic and Medicinal Chemistry, 2002, vol. 10, # 5, p. 1399 - 1415
[51] Tetrahedron, 2003, vol. 59, # 18, p. 3307 - 3314
[52] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 22, p. 5699 - 5702
[53] Journal of Organic Chemistry, 2007, vol. 72, # 5, p. 1830 - 1833
[54] Tetrahedron Letters, 2005, vol. 46, # 45, p. 7705 - 7709
[55] Tetrahedron Letters, 2005, vol. 46, # 30, p. 4985 - 4987
[56] Bioorganic and Medicinal Chemistry, 2004, vol. 12, # 19, p. 5171 - 5180
[57] Bioorganic and Medicinal Chemistry, 2006, vol. 14, # 7, p. 2253 - 2265
[58] Journal of Organic Chemistry, 2000, vol. 65, # 5, p. 1590 - 1596
[59] Organic Letters, 2007, vol. 9, # 15, p. 2939 - 2941
[60] Organic letters, 1999, vol. 1, # 10, p. 1513 - 1516
[61] Bioorganic and Medicinal Chemistry, 2008, vol. 16, # 1, p. 578 - 585
[62] Patent: WO2005/42533, 2005, A2, . Location in patent: Page/Page column 54
[63] Patent: EP1852436, 2007, A1, . Location in patent: Page/Page column 15
[64] Angewandte Chemie - International Edition, 2007, vol. 46, # 44, p. 8431 - 8435
[65] Chemical Communications, 2009, # 4, p. 463 - 465
[66] Patent: US2009/163472, 2009, A1, . Location in patent: Page/Page column 21
[67] Patent: WO2004/99185, 2004, A1, . Location in patent: Page 22
[68] Chemistry - A European Journal, 2010, vol. 16, # 18, p. 5333 - 5342
[69] Chemistry - A European Journal, 2010, vol. 16, # 35, p. 10691 - 10706
[70] Organic Letters, 2010, vol. 12, # 24, p. 5708 - 5711
[71] Patent: WO2011/50146, 2011, A1, . Location in patent: Page/Page column 45
[72] Patent: WO2013/49164, 2013, A1, . Location in patent: Paragraph 802-803
[73] Patent: WO2013/49174, 2013, A1, . Location in patent: Paragraph 0846-0847
[74] Angewandte Chemie - International Edition, 2013, vol. 52, # 36, p. 9539 - 9543[75] Angew. Chem., 2013, vol. 125, # 36, p. 9718 - 9722
[76] Organic Process Research and Development, 2003, vol. 7, # 5, p. 649 - 654
[77] Chemistry - A European Journal, 2014, vol. 20, # 13, p. 3813 - 3824
[78] Patent: US2014/179668, 2014, A1, . Location in patent: Paragraph 0859
[79] Tetrahedron Asymmetry, 2017, vol. 28, # 1, p. 175 - 180
[80] Patent: WO2009/158571, 2009, A1, . Location in patent: Page/Page column 400-401
  • 5
  • [ 51-35-4 ]
  • [ 75-36-5 ]
  • [ 40216-83-9 ]
YieldReaction ConditionsOperation in experiment
88% With thionyl chloride In methanol Step C-1.
Preparation of an ester compound
To a suspension of trans-4-hydroxy-L-proline (200 g: 1.525 mole) in methanol (800 ml), acetylchloride (163 ml: 2.288 mole) is added dropwise under ice cooling in a nitrogen atmosphere.
The mixture is warmed to room temperature, mixed with thionyl chloride (55.7 ml: 0.763 mole), and stirred for 4 hours at 40° C. to give (2S,4R)-4-hydroxy-2-methoxycarbonylpyrrolidine hydrochloride (244.27 g). Yield: 88percent.
Colorless crystals. NMR δ(D2 O) ppm: 1.8 to 2.0(m, 1H), 2.0 to 2.2(m, 1H), 2.9 to 3.1(m, 1H), 3.17(dd, J=12.6 Hz, J=3.6 Hz, 1H), 3.49(s, 3H), 4.2 to 4.4(m, 2H). IR ν (KBr) cm-1: 3380, 3330, 2695, 2960, 1742.
Reference: [1] Patent: US5317016, 1994, A,
  • 6
  • [ 67-56-1 ]
  • [ 13726-69-7 ]
  • [ 40216-83-9 ]
YieldReaction ConditionsOperation in experiment
99% at 20℃; for 12 h; Compound 20r (2 g, 8.6 mmol) was taken up with a solution of HC1 (g) in methanol (4 M, 40 mL). The mixture was stirred at ambient temperature for 12 hrs. After that, the reaction mixture was concentrated under reduced pressure to afford compound 20s (1.6 g, yield 99percent) as a white solid.
Reference: [1] Patent: WO2012/37259, 2012, A1, . Location in patent: Page/Page column 74
  • 7
  • [ 74844-91-0 ]
  • [ 40216-83-9 ]
Reference: [1] Patent: US9458138, 2016, B1, . Location in patent: Page/Page column 41; 47
  • 8
  • [ 75-36-5 ]
  • [ 51-35-4 ]
  • [ 40216-83-9 ]
Reference: [1] Archiv der Pharmazie, 2003, vol. 336, # 11, p. 495 - 503
  • 9
  • [ 77-76-9 ]
  • [ 51-35-4 ]
  • [ 40216-83-9 ]
Reference: [1] Acta Chemica Scandinavica, 1990, vol. 44, # 3, p. 243 - 251
  • 10
  • [ 40216-83-9 ]
  • [ 61478-26-0 ]
Reference: [1] Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1989, vol. 28, # 1-11, p. 294 - 296
[2] Synthesis, 1990, vol. 1, # 10, p. 925 - 930
[3] Tetrahedron Letters, 2013, vol. 54, # 39, p. 5345 - 5347
[4] Patent: US2014/179680, 2014, A1,
  • 11
  • [ 24424-99-5 ]
  • [ 40216-83-9 ]
  • [ 61478-26-0 ]
Reference: [1] Patent: WO2015/6740, 2015, A2,
  • 12
  • [ 24424-99-5 ]
  • [ 40216-83-9 ]
  • [ 74844-91-0 ]
YieldReaction ConditionsOperation in experiment
100% With triethylamine In dichloromethane at 0 - 20℃; for 2 h; To a stirred suspension of the hydrochloride salt obtained in step I (14.5 g, 0.1 mol) in CH2Cl2 (400 mL) cooled to 0°C was added Et3N (28 mL, 0.2 mol), DMAP (0.61 g,5 mmol), and Boc anhydride (27.5 mL, 0.12 mol). The reaction mixture was gradually warmed to room temperature and stirred for 2 h. The solvent was then removed under vacuum and ether was added to the residual solid. The solid was filtered through a sintered funnel and washed thoroughly with ether. The filtrate was evaporated under reduced pressure. The residue was dissolved in CH2Cl2 and washed with sat. NaCl and sat.NaHCO3 followed by drying over anhydrous Na2SO4. The solvent was evaporated under reduced pressure to obtain light yellow oil which solidified under high vacuum. The resulting solid was triturated several times with hexanes. The solid was dried under high vacuum yielding l-ter/-butyl 2-methyl (2S, 4i?)-4-hydroxypyrrolidine-l,2-dicarboxylate as a white solid (24.5 g) in 100percent yield. (M+l) 245; 1H NMR (CDCl3) 300 MHz δ 4.54-4.37 <n="62"/>(m, 2H), 3.75 (s, 3H), 3.70-3.40 (m, 2H), 2.48-2.21 (m, 2H), 2.13-2.0 (m, IH), 1.46 (s, 3H), 1.41 (s, 6H).
100%
Stage #1: With triethylamine In dichloromethane at 0℃; for 0.166667 h;
Stage #2: at 20℃; for 12 h;
At room temperature,4A (27.7 g, 152.6 mmol) was dissolved in dichloromethane (150 mL)After cooling to 0 ° C, triethylamine (38.6 g, 381.5 mmol) was added and stirred for 10 minutes.A mixture of two or three terephthalate (39.9 g, 183.1 mmol)In dichloromethane (50 mL) was added dropwise to the reaction mixture, and the reaction was stirred at room temperature for 12 hours.The organic phase was washed successively with hydrochloric acid (0.5 mol / L, 150 mL x 1), sodium bicarbonate solution (100 mL x 1), saturated brine solution (100 mL x 1).Dried over anhydrous magnesium sulfate, filtered, and the filtrate was concentrated under reduced pressure to give pale yellow liquid 4B (28.0 g, yield 100percent).
99% With triethylamine In dichloromethane at 0 - 20℃; Methyl (2S,4R)-N-tert-Butoxycarbonyl-4-hydroxy-2-pyrrolidinecarboxylate. L-trans-4-Hydroxyproline methyl ester hydrochloride (25.00 g, 138.0 mmol) was dissolved in dichloromethane (300 mL) and triethylamine (58.0 mL, 413 mmol). The solution was cooled to 0° C. and then di-tert-butyldicarbonate (33.00 g, 151.0 mmol) was added in small portions. After stirring at room temperature overnight, the mixture was concentrated to a thick white sludge. The residue was dissolved in ethyl acetate and the organic layer was washed successively with NH4Cl/H2O, NaHCO3/H2O and brine. The organic extracts were dried over MgSO4, filtered, and concentrated to give 33.0 g (99percent) of desired product as a colorless oil. LC/MS (M+Na)+ m/z=267.9. 1H NMR (CDCl3) δ 4.50 (m, 1H), 4.40 (m, 1H), 3.75 (s, 3H), 3.43-3.68 (m, 2H), 2.30 (m, 1H), 1.95-2.15 (m, 2H), 1.42 and 1.45 (s, 9H).
99% With triethylamine In dichloromethane at 0 - 20℃; Step AMethyl (2S,4f?)-N-iert-Butoxycarbonyl-4-hydroxy-2-pyrrolidinecarboxylate. L-trans-A- Hydroxyproline methyl ester hydrochloride (25.00 g, 138.0 mmol) was dissolved in dichloromethane (300 mL) and triethylamine (58.0 mL, 413 mmol). The solution was cooled to 0 °C and then di-terf-butyldicarbonate (33.00 g, 151.0 mmol) was added in small portions. After stirring at room temperature overnight, the mixture was concentrated to a thick white sludge. The residue was dissolved in ethyl acetate and the organic layer was washed successively with NH4CI/H20, NaHC03/H20 and brine. The organic extracts were dried over MgS04, filtered, and concentrated to give 33.0 g (99percent) of desired product as a colorless oil. LC/MS (M+Na)+ m/z = 267.9. 1H NMR (CDCI3) δ 4.50 (m, 1 H), 4.40 (m, 1 H), 3.75 (s, 3H), 3.43-3.68 (m, 2H), 2.30 (m, 1 H), 1.95-2.15 (m, 2H), 1 .42 and 1 .45 (s, 9H).
97% With triethylamine In dichloromethane at 0℃; for 17 h; A solution of 14·HCl (13.3 g, 73.9 mmol) and NEt3 (26.0 mL, 192 mmol) in CH2Cl2 (160 mL) was cooledto 0 °C and di-tert-butyl dicarbonate (17.7 g, 81.3 mmol) was added portion-wise. The ice bath wasallowed to expire and stirring was continued for 17 h. The reaction mixture was diluted with CH2Cl2(100 mL) and washed with hydrochloric acid (1M; 100 mL). The organic extract was further washedwith H2O (100 mL), saturated aqueous sodium hydrogencarbonate (100 mL), brine (100 mL) andthen dried (MgSO4) and the solvent removed under reduced pressure to yield the desired alcohol(17.8 g, 72.9 mmol, 97percent) as a yellow oil (and as a mixture of conformers);−60.4 (0.98, CHCl3);νmax/cm-1 3431, 2978, 1748, 1677, 1411, 1367, 1158, 894, 733, 551; δH (500 MHz; CDCl3) 4.38–4.46 (2H, m), 3.71 (3 H, s), 3.42–3.59 (2 H, m), 2.24–2.47 (2 H, m), 2.04–2.10 (1 H, m), 1.39–1.43 (9 H, m) δC(125 MHz; CDCl3) 173.8, 154.1, 80.4, 69.9, 69.2, 58.0, 54.7, 52.0, 39.1, 38.4, 28.4, 28.3; m/z (+ESI)289 ([M + Na], 100).
96% With triethylamine In chloroform at 25 - 50℃; for 3.5 - 4 h; Chloroform (1.4 L) and compound methyl (2S,4f?)-4-hydroxypyrrolidine-2-carboxylate hydrochloride (544.8 g) were mixed under stirring. Triethylamine (464 mL, 3.3 mol) was added under cooling to the mixture and the precipitate dissolved almost completely. A solution of BoC2O (687.5 g, 3.15 mol) in chloroform (1 L) was added dropwise at the temperature less than 25 0C for 1.5-2 h. Then the reaction mixture was heated to 45-50 0C and kept at this temperature for 2 h under stirring. The course of the reaction was monitored by TLC (chloroform/methanol 10:3). Then the reaction mixture was washed sequentially with water (50O mL, 20O mL and 10O mL), a solution of citric acid (28.8 g, 0.15 mol) in water (100 mL), a solution of sodium hydroxide (12 g) in water (100 mL) and water. The solution was dried with potassium carbonate for 2-3 h and then evaporated to give a viscous light-yellow liquid. The liquid was treated with diethyl ether (400 mL), stirred and cooled for 1 h. The product was washed with diethyl ether (3 x 300 mL) and dried to constant weight to give 615-620 g of 3 as white crystals. The mother solution of ether was evaporated and cooled to room temperature. Ether (50 mL) and a small amount of the product were added to the solution. The precipitate formed was filtered, washed with ether and dried to give 50 g of the title compound. The total yield was 96percent.
91%
Stage #1: With triethylamine In dichloromethane at 0℃; for 0.5 h;
Stage #2: With dmap In dichloromethane at 20℃; for 18 h;
Add triethylamine (1.56 mol, 157.5 g) to a solution of methyl ester hydrochloride in dry dichloromethane (2 L) at 0° C. and stir for 30 min.
Then add N,N-dimethylaminopyridine (0.10 mol, 13 g) and di-tert-butyl dicarbonate (0.85 mol, 185.7 g) consecutively.
Warm the reaction mixture to room temperature and stir for 18 h.
Quench the reaction mixture with water, separate the organic layer, and wash with water and saturated sodium bicarbonate solution.
Dry the organic layer over anhydrous sodium sulfate, filter, and concentrate under reduced pressure to obtain the title compound (160 g, 91percent) as viscous oil. ES-MS m/z 246.1 [M+1]+.
91% With sodium hydrogencarbonate In 1,4-dioxane at 20℃; for 24 h; A solution of (2S,4R)-methyl 4-hydroxypyrrolidine-2-carboxylate hydrochloride (10) (0.5g, 2.75mmol) in dioxane (15mL) was added (Boc)2O (721mg, 3.3mmol) and saturated NaHCO3 (10.5mL). The reaction was stirred at room temperature overnight. The solvent was then removed in vacuo and CH2Cl2 was added. The organics were washed with H2O twice and saturated NaCl once, then dried, filtered and concentrated. The residue was purified by flas h chromatography on silica gel, eluted with a mixture of EA/PE (1:5, v/v), to afford 11 (611mg, 91percent) as a white solid. 1H NMR (CDCl3, 300MHz): δ 4.35–4.48 (m, 2H), 3.72 (s, 3H), 3.46–3.65 (m, 2H), 2.03–2.29 (m, 2H), 1.39 (s, 9H). MS (ESI) m/z 246 [M+H]+.
91% With triethylamine In dichloromethane at 0 - 25℃; for 16.5 h; To a stirred solution of compound 1 (100.0 g, 552 mol) in DCM (1 L), Et3N (230 mL, 1.65 mol) was added at 0 °C and stirred for 15 min. B0C2O (152 mL, 662 mmol) was added drop wise to the reaction mixture at 0 °C over 30 min and stirred at room temperature for 16 h. After consumption of the starting material (by TLC), the reaction mixture was quenched with ice-cold water (500 mL) and extracted with DCM (3 x 300 mL). The combined organic layer was washed with brine (150 mL), dried over Na2S04 and concentrated under reduced pressure. The residue was purified by column chromatography to afford compound 2 (123.0 g, 91percent) as a colorless solid. H NMR (400 MHz, DMSO-cfe): δ 5.09 (d, / = 3.6 Hz, 1H), 4.29 - 4.15 (m, 2H), 3.64 (m, 3H), 3.45 - 3.21 (m, 2H), 2.14 - 2.09 (m, 1H), 1.95 - 1.82 (m, 1H), 1.39 - 1.32 (m, 9H).
90.1% With triethylamine In 1,4-dioxane; water at 0 - 20℃; Methyl 4-trans-hydroxy-prolinate hydrochloride (1.45 g, 8 mmol) was dissolved in a mixture of dioxane and water (2:1, v/v, 20 mL) at 0 °C. To the solution was added triethylamine (1.7 mL, 12 mmol) and Boc anhydride (2.0 g, 8.8 mmol). The reaction mixture was then stirred at room temperature for 5 h and evaporated in vacuo. The resulting residue was washed with ethyl acetate (20 mL) and water (15 mL). The aqueous layer was successively extracted with ethyl acetate (20 mL x 2). The combined organic layer was washed with HCl (0.5 M, 5 mL), water (5 mL x 2), sodium carbonate (5percent, 5 mL), water (5 mL x 2), and brine (10 mL) and finally was dried overnight by anhydrous MgSO4. The product was obtained as a white solid. Yield, 1.76 g, 90.1percent, mp 92-94 °C, [α]25D -64.0 (c 1.0, CHCl3).
90% With triethylamine In dichloromethane at 0 - 20℃; for 4 h; Boc2O (94.0 g, 428 mmol) was added into a solution of H-2 (65.0 g, 357.0 mmol) and Et3N (124.0 mL, 892 mmol) in DCM (300 mL) at 0 °C. The resulting mixture was stirred at r.t. for 4 hours before the reaction solution was washed with 1 N HCI (300 mL), brine (300 mL) and dried over Na2SO4, filtered and concentrated to dryness to give H-3 (79.0 g, 90percent) as a white solid.
89% With triethylamine In dichloromethane at 20℃; (a)
(2S,4R)-4-Hydroxy-pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester 2-methyl ester
To a solution of (2S,4R)-4-hydroxy-pyrrolidine-2-carboxylic acid methyl ester HCl (10 g, 55.1 mmol) in DCM (100 mL) was added triethylamine (16.73 g, 165.3 mmol) and di-tert-butyl dicarbonate (14.41 g, 66.1 mmol).
The reaction mixture was stirred at RT overnight, concentrated, and purified by column chromatography (3:1 petroleum ether:EtOAc) to give the title intermediate (12 g, 89percent yield) 1H NMR (400 MHz, CDCl3): δ(ppm) 4.48 (m, 1H), 4.38 (m, 1H), 3.72 (s, 3H), 3.63 (m, 1H), 3.45 (m, 1H), 2.29 (m, 1H), 2.06 (m, 2H), 1.39 (s, 9H).
88% With triethylamine In dichloromethane at 20℃; Acetyl chloride (14 mL, 198 mmol) was slowly added into the anhydrous methanol (100 mL) in an ice bath. After stirred for30 min, compound 2 (7.87 g, 60.0 mmol) was added to the solution.Then the reaction was refluxed for 4 h in an oil bath. After the methanol was removed under reduced pressure, about 10 mLacetone was added into the residue and filtered to give 8.67 g of(2S,4R)-methyl 4-hydroxypyrrolidine-2-carboxylate hydrochlorideas a white powder. Yield: 88percent, mp: 160–164 °C. Di-tert-butyl dicarbonate (11.42 g, 52.3 mmol) in 50 mL dichloromethane was slowly added to the solution of (2S,4R)-methyl 4-hydroxypyrrolidine-2-carboxylate hydrochloride (8.64 g, 47.6 mmol), triethylamine(13.5 mL, 96.0 mmol) in 150 mL dichloromethane. After stirred overnight at room temperature, the reaction mixture was concentrated under reduced pressure and dissolved with EtOAc. The EtOAc layer was washed two times by 1 M citric acid, saturated sodium bicarbonate and brine, respectively. Finally, the organic layer was dried over anhydrous MgSO4 and concentrated to obtain compound 3 as a white powder.
86% With sodium hydrogencarbonate In methanol To a solution of trans-4-hydroxy-l .-proline methyl ester (18.0 g, 107.0 mmol) in the mixture of MeOH (150 ml) and sodium bicarbonate solution (2.0 M, 350 ml) was added (BOQ2O (30.0 g, 137.6 mmol) in three portions in 4 h. After stirring for an additional 4 h, the reaction was concentrated to -350 ml and extracted with EtOAc (4 x 80 mL). The combined organic layers were washed with brine (100 mL), dried ( MgS( ).t ). filtered, concentrated and purified by SiO.-> chromatography (1 : 1 hexanes/EtOAc) to give the title compound (22.54 g, 86percent yield). LSI MS m/z+ 268.2 (M + Na).
86% With sodium hydrogencarbonate In methanol; water for 8 h; To a solution of trans-4-hydroxy-L-proline methyl ester (18.0 g, 107.0 mmol) in the mixture of MeOH (150 ml) and sodium bicarbonate solution (2.0 M, 350 ml) was added Boc2O (30.0 g, 137.6 mmol) in three portions in 4 h. After stirring for an additional 4 h, the reaction was concentrated to ~350 ml and extracted with EtOAc (4 × 80 mL). The combined organic layers were washed with brine (100 mL), dried (MgSO4), filtered, concentrated and purified by SiO2 column chromatography (1:1 hexanes/EtOAc) to give the title compound (22.54 g, 86percent yield). ESI MS m/z 268.2 ([M+Na]+).
82% With triethylamine In dichloromethane Step C-2.
Preparation of a Boc compound
To a suspension of (2S,4R)-4-hydroxy-2-methoxycarbonylpyrrolidine hydrochloride (12.71 g: 70 mmole) in dichloromethane (70 ml), triethylamine (10.7 ml: 77 mmole) is added dropwise under ice cooling in a nitrogen atmosphere.
The mixture is stirred for 5 min. at room temperature.
A solution of di-t-butyl dicarbonate (19.10 g: 87.5 mmole) in dichloromethane (72 ml) is added dropwise thereto, and the mixture is stirred for 45 minutes at room temperature to give (2S,4R)-1-t-butoxycarbonyl-4-hydroxy-2-methoxycarbonylpyrrolidine (14.06 g). Yield: 82percent.
Colorless oil. NMR δ(CDCl3) ppm: 1.44(d, J=9.6 Hz, 9H), 1.9 to 2.4(m, 3H), 3.4 to 3.7(m, 2H), 3.74 (s, 3H), 4.3 to 4.6(m, 2H).
64% With triethylamine In dichloromethane at 20℃; for 5 h; To a stirred solution of V (3.0 g, 12.24 mmol) in DCM (30 mL) was added Et3N(1.85 g, 18.31 mmol) and Boc anhydride (2.92 g, 13.46 mmol). Stirring was continued at rt for 5 h after which the reaction was quenched with water. The organic layer was separated, dried and concentrated under reduced pressure. The residue was purified by column chromatography (SiO2, 60-120, 100percent ethyl acetate) to give 3' (3.2 g, 64percent) as a white solid.
91 %Spectr.
Stage #1: With triethylamine In dichloromethane at 0℃;
Stage #2: With triethylamine In dichloromethane at 0℃; for 12 h;
Triethylamine (10.1 g, 100 mmol), then di-ter-butyl-dicarbonate (8.3 g, 38.0 mmol) are added to the suspension of (2S,4R)-4-hydroxy-2-(methoxycarbonyl)- pyrrolidine chloride (2) (6.32 g, 34.8 mmol) in 45 ml of anhydrous CH2Cl2 at 00C. The reaction is carried out in ice/salt bath for 12 hours under N2 flux. Then, the reaction mixture is treated with a 1 M H3PO4 solution (158 ml), then with a Na- HCO3 saturated solution (3x45 ml). The obtained organic phase is dried over sodium sulfate, evaporated to dryness and l-ter-butyl-2-methyl-(2S,4R)-4-hydroxy- pyrrolidine-l,2-dicarboxylate (3) is obtained. Pale yellow oil, yield 91percent (calcu- lated by 1H NMR).1H NMR (CDCl3, 500 MHz): δ 1.37 (s, 6H), 1.43 (s, 3H), 2.03 (m, IH), 2.26 (m, IH), 2.97 (m, IH), 3.46 (m, IH), 3.59 (m, IH), 3.69 (s, 3H), 4.36 (m, IH), 4.44 (m, IH).13C NMR (CDCl3, 50 MHz): δ 27.9, 37.1, 54.0, 57.9, 61.3, 72.0, 83.4, 160.1, 168.4.Elemental analysis. Calculated for CHHI9NO5: C, 53.87; H, 7.81; N, 5.71. Found: C, 53.84; H, 7.77; N, 5.69. Theoretical mass for CHHI9NO5: 245.27. Found: 245.25.
27 g With dmap; triethylamine In dichloromethane at 0 - 20℃; for 3 h; Step-2:
Synthesis of (2S,4R)-1-tertbutoxycarbonyl-2-methoxycarbonyl-4-hydroxy pyrrolidine
To a suspension of (2S,4R)-methyl 4-hydroxypyrrolidine-2-carboxylate hydrochloride (20.5 g, 113.25 mmol) in DCM was added triethylamine (31.4 mL, 226.5 mmol), DMAP (690 mg, 5.66 mmol) and di-tert-butyl dicarbonate (29.6 g, 135.9 mmol) at 0° C.
The reaction mixture was allowed to stir at RT for 3 h. the reaction mixture was washed with water (3*150 mL) followed by saturated NaHCO3 (150 mL) and brine (150 mL).
The organic layer was dried over anhydrous sodium sulfate and concentrated under vacuum to afford (2S,4R)-1-tertbutoxycarbonyl-2-methoxycarbonyl-4-hydroxy pyrrolidine as oil (27 g).

Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 22, p. 5699 - 5702
[2] Patent: WO2007/113634, 2007, A1, . Location in patent: Page/Page column 60-61
[3] Tetrahedron Asymmetry, 2009, vol. 20, # 12, p. 1433 - 1436
[4] Journal of Chemical Research, 2009, # 11, p. 668 - 670
[5] Tetrahedron Letters, 2012, vol. 53, # 30, p. 3847 - 3849
[6] Patent: TW2017/8221, 2017, A, . Location in patent: Page/Page column 44; 45
[7] Patent: US2005/192302, 2005, A1, . Location in patent: Page/Page column 41
[8] Patent: WO2012/114223, 2012, A1, . Location in patent: Page/Page column 72-73
[9] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 12, p. 3767 - 3770
[10] Tetrahedron Letters, 2013, vol. 54, # 39, p. 5345 - 5347
[11] Tetrahedron, 2003, vol. 59, # 18, p. 3307 - 3314
[12] Patent: WO2006/27694, 2006, A1, . Location in patent: Page/Page column 69-70
[13] Tetrahedron Letters, 1998, vol. 39, # 10, p. 1169 - 1172
[14] Tetrahedron Letters, 2003, vol. 44, # 42, p. 7809 - 7812
[15] Journal of Medicinal Chemistry, 1983, vol. 26, # 4, p. 549 - 554
[16] Heterocycles, 2003, vol. 60, # 5, p. 1203 - 1209
[17] Bioorganic and Medicinal Chemistry, 2008, vol. 16, # 1, p. 578 - 585
[18] Tetrahedron Asymmetry, 1998, vol. 9, # 1, p. 47 - 53
[19] Patent: US2009/163472, 2009, A1, . Location in patent: Page/Page column 21
[20] European Journal of Medicinal Chemistry, 2014, vol. 86, p. 242 - 256
[21] Patent: WO2018/26792, 2018, A1, . Location in patent: Page/Page column 138-139
[22] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 12, p. 3730 - 3733
[23] Patent: WO2011/50146, 2011, A1, . Location in patent: Page/Page column 45
[24] ACS Medicinal Chemistry Letters, 2013, vol. 4, # 10, p. 969 - 973
[25] Chemical Communications, 2014, vol. 50, # 68, p. 9657 - 9660
[26] Helvetica Chimica Acta, 1996, vol. 79, # 7, p. 1825 - 1842
[27] Journal of Organic Chemistry, 2001, vol. 66, # 10, p. 3593 - 3596
[28] Patent: US2013/115194, 2013, A1, . Location in patent: Paragraph 0410
[29] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 24, p. 7685 - 7693
[30] Patent: WO2015/28850, 2015, A1, . Location in patent: Page/Page column 85
[31] Patent: WO2016/59622, 2016, A2, . Location in patent: Page/Page column 124
[32] Organic Letters, 2018, vol. 20, # 1, p. 162 - 165
[33] Patent: US5317016, 1994, A,
[34] Journal of the Chemical Society - Perkin Transactions 1, 1998, # 22, p. 3777 - 3793
[35] Journal of the Chemical Society. Perkin Transactions 1, 2001, # 20, p. 2623 - 2631
[36] Dalton Transactions, 2016, vol. 45, # 34, p. 13483 - 13490
[37] Patent: WO2009/158571, 2009, A1, . Location in patent: Page/Page column 400; 401
[38] Journal of Fluorine Chemistry, 2015, vol. 173, p. 77 - 83
[39] Bioorganic and Medicinal Chemistry, 2002, vol. 10, # 5, p. 1399 - 1415
[40] Tetrahedron Letters, 2005, vol. 46, # 30, p. 4985 - 4987
[41] Bioorganic and Medicinal Chemistry, 2006, vol. 14, # 7, p. 2253 - 2265
[42] Journal of Organic Chemistry, 2000, vol. 65, # 5, p. 1590 - 1596
[43] Organic Letters, 2007, vol. 9, # 15, p. 2939 - 2941
[44] Patent: WO2005/42533, 2005, A2, . Location in patent: Page/Page column 54-55
[45] Chemical Communications, 2009, # 4, p. 463 - 465
[46] Patent: WO2004/99185, 2004, A1, . Location in patent: Page 22-23
[47] Patent: WO2007/65883, 2007, A1, . Location in patent: Page/Page column 6; 13-14
[48] Journal of Organic Chemistry, 2012, vol. 77, # 11, p. 4917 - 4923
[49] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 23, p. 7418 - 7429
[50] European Journal of Medicinal Chemistry, 2014, vol. 75, p. 111 - 122
[51] Patent: US2014/179668, 2014, A1, . Location in patent: Paragraph 0860
[52] Patent: US2014/179680, 2014, A1, . Location in patent: Paragraph 0778
[53] Patent: WO2015/6740, 2015, A2, . Location in patent: Page/Page column 97; 98
[54] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 18, p. 4016 - 4022
  • 13
  • [ 1070-19-5 ]
  • [ 40216-83-9 ]
  • [ 74844-91-0 ]
Reference: [1] Synthesis, 1990, vol. 1, # 10, p. 925 - 930
[2] Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1989, vol. 28, # 1-11, p. 294 - 296
  • 14
  • [ 40216-83-9 ]
  • [ 102195-80-2 ]
Reference: [1] Tetrahedron Letters, 2005, vol. 46, # 30, p. 4985 - 4987
[2] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 22, p. 5699 - 5702
[3] Tetrahedron Letters, 2003, vol. 44, # 42, p. 7809 - 7812
[4] Journal of Organic Chemistry, 2001, vol. 66, # 10, p. 3593 - 3596
[5] Tetrahedron Letters, 1998, vol. 39, # 10, p. 1169 - 1172
[6] Tetrahedron Letters, 2012, vol. 53, # 30, p. 3847 - 3849
[7] Patent: WO2011/50146, 2011, A1,
[8] Patent: US2013/115194, 2013, A1,
[9] Patent: WO2015/28850, 2015, A1,
[10] Patent: WO2016/59622, 2016, A2,
  • 15
  • [ 40216-83-9 ]
  • [ 82911-69-1 ]
  • [ 122350-59-8 ]
Reference: [1] Organic Letters, 2007, vol. 9, # 21, p. 4211 - 4214
  • 16
  • [ 40216-83-9 ]
  • [ 88744-04-1 ]
  • [ 122350-59-8 ]
Reference: [1] Chemistry - A European Journal, 2009, vol. 15, # 40, p. 10649 - 10657
  • 17
  • [ 40216-83-9 ]
  • [ 51154-06-4 ]
Reference: [1] Organic Letters, 2018, vol. 20, # 1, p. 162 - 165
  • 18
  • [ 40216-83-9 ]
  • [ 32968-78-8 ]
Reference: [1] Patent: WO2014/25805, 2014, A1,
  • 19
  • [ 40216-83-9 ]
  • [ 113451-59-5 ]
Reference: [1] Tetrahedron Letters, 2013, vol. 54, # 39, p. 5345 - 5347
  • 20
  • [ 40216-83-9 ]
  • [ 114676-93-6 ]
Reference: [1] ACS Medicinal Chemistry Letters, 2013, vol. 4, # 10, p. 969 - 973
  • 21
  • [ 40216-83-9 ]
  • [ 88043-21-4 ]
Reference: [1] Patent: US2013/115194, 2013, A1,
[2] Angewandte Chemie - International Edition, 2013, vol. 52, # 36, p. 9539 - 9543[3] Angew. Chem., 2013, vol. 125, # 36, p. 9718 - 9722
[4] Patent: WO2018/26792, 2018, A1,
  • 22
  • [ 40216-83-9 ]
  • [ 203866-15-3 ]
Reference: [1] Tetrahedron Letters, 1998, vol. 39, # 10, p. 1169 - 1172
  • 23
  • [ 40216-83-9 ]
  • [ 203866-17-5 ]
Reference: [1] Tetrahedron Letters, 2003, vol. 44, # 42, p. 7809 - 7812
[2] Tetrahedron Letters, 1998, vol. 39, # 10, p. 1169 - 1172
  • 24
  • [ 40216-83-9 ]
  • [ 203866-14-2 ]
Reference: [1] Tetrahedron Letters, 1998, vol. 39, # 10, p. 1169 - 1172
  • 25
  • [ 40216-83-9 ]
  • [ 203866-13-1 ]
Reference: [1] Tetrahedron Letters, 1998, vol. 39, # 10, p. 1169 - 1172
[2] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 23, p. 7418 - 7429
[3] European Journal of Medicinal Chemistry, 2014, vol. 75, p. 111 - 122
[4] European Journal of Medicinal Chemistry, 2014, vol. 86, p. 242 - 256
  • 26
  • [ 40216-83-9 ]
  • [ 203866-18-6 ]
Reference: [1] Tetrahedron Letters, 1998, vol. 39, # 10, p. 1169 - 1172
  • 27
  • [ 40216-83-9 ]
  • [ 203866-16-4 ]
Reference: [1] Tetrahedron Letters, 2003, vol. 44, # 42, p. 7809 - 7812
[2] Tetrahedron Letters, 1998, vol. 39, # 10, p. 1169 - 1172
[3] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 23, p. 7418 - 7429
[4] European Journal of Medicinal Chemistry, 2014, vol. 75, p. 111 - 122
[5] European Journal of Medicinal Chemistry, 2014, vol. 86, p. 242 - 256
  • 28
  • [ 40216-83-9 ]
  • [ 203866-19-7 ]
Reference: [1] Tetrahedron Letters, 1998, vol. 39, # 10, p. 1169 - 1172
  • 29
  • [ 40216-83-9 ]
  • [ 426844-76-0 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 23, p. 7418 - 7429
[2] European Journal of Medicinal Chemistry, 2014, vol. 75, p. 111 - 122
[3] European Journal of Medicinal Chemistry, 2014, vol. 86, p. 242 - 256
  • 30
  • [ 572924-00-6 ]
  • [ 40216-83-9 ]
  • [ 877069-25-5 ]
Reference: [1] Organic Process Research and Development, 2015, vol. 19, # 1, p. 132 - 138
[2] Organic Process Research and Development, 2015, vol. 19, # 1, p. 132 - 138
[3] Organic Process Research and Development, 2015, vol. 19, # 1, p. 132 - 138
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 40216-83-9 ]

Faldaprevir Intermediates

Chemical Structure| 62-23-7

[ 62-23-7 ]

4-Nitrobenzoic acid

Related Functional Groups of
[ 40216-83-9 ]

Amino Acid Derivatives

Chemical Structure| 2133-40-6

[ 2133-40-6 ]

H-Pro-OMe.HCl

Similarity: 0.91

Chemical Structure| 65365-28-8

[ 65365-28-8 ]

H-D-Pro-OMe.HCl

Similarity: 0.91

Chemical Structure| 79397-50-5

[ 79397-50-5 ]

H-DL-Pro-OMe.HCl

Similarity: 0.91

Chemical Structure| 367453-05-2

[ 367453-05-2 ]

H-Hyp(tBu)-OtBu.HCl

Similarity: 0.90

Chemical Structure| 18650-38-9

[ 18650-38-9 ]

H-D-HoPro-OMe.HCl

Similarity: 0.88